Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr Medical Dialogues Bureau5 Nov 2019 12:55 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 12:00 PM ISTOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor Medical Dialogues Bureau9 July 2019 12:49 PM ISTMumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...